Research & development decreased 20.6%
Research & development changed -20.6% from the comparable as-filed period.
$24.1M→$19.2M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ADPT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Trade receivables increased 11.8%
Trade receivables changed +11.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$44.3M→$49.5M4 prior comparisons
Free-cash-flow margin moved 1162 bp higher
Free-cash-flow margin changed +1162 basis points from the comparable as-filed period.
-22.22%→-10.60%2 prior comparisons
Operating cash-flow margin moved 1217 bp higher
Operating cash-flow margin changed +1217 basis points from the comparable as-filed period.
-21.11%→-8.94%2 prior comparisons
R&D / revenue moved 1422 bp lower
R&D / revenue changed -1422 basis points from the comparable as-filed period.
40.99%→26.77%2 prior comparisons
Inventory increased 24.9%
Inventory changed +24.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$8.4M→$10.5M4 prior comparisons
Debt / assets moved 2689 bp lower
Debt / assets changed -2689 basis points from the comparable as-filed period.
26.89%→0.00%2 prior comparisons
Debt / revenue moved 22685 bp lower
Debt / revenue changed -22685 basis points from the comparable as-filed period.
226.85%→0.00%1 prior comparisons
Receivables / revenue moved 602 bp lower
Receivables / revenue changed -602 basis points from the comparable as-filed period.
75.21%→69.20%2 prior comparisons
Stock-based compensation decreased 16.8%
Stock-based compensation changed -16.8% from the comparable as-filed period.
$13.4M→$11.1M2 prior comparisons
Capex / revenue moved 54 bp higher
Capex / revenue changed +54 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.11%→1.65%2 prior comparisons
Cost of revenue increased 12.0%
Cost of revenue changed +12.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$18.0M→$20.2M2 prior comparisons
Net debt changed across a sign change
Net debt changed -287.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$90.4M→-$169.9M1 prior comparisons
Inventory / revenue moved 40 bp higher
Inventory / revenue changed +40 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
14.27%→14.67%2 prior comparisons
Current liabilities decreased 4.8%
Current liabilities changed -4.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$92.1M→$87.7M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.